Browse the corpus

Dyspnea is a subjective respiratory sensation characterized by insufficient air intake arising from complex physiologic, psychological, social, and environmental interactions. Acute presentations occur in pulmonary embolism, asthma exacerbation, pneumonia, or heart failure, whereas chronic manifestations develop in chronic obstructive pulmonary disease, interstitial lung disease, obesity, or neuromuscular weakness. The symptom may appear as air hunger, chest constriction, tachypnea, or increased respiratory effort, often restricting activity and diminishing functional capacity. Dyspnea is a clinical manifestation rather than a discrete disease entity. A structured, interprofessional evaluation grounded in detailed history, comprehensive physical examination, and condition-specific diagnostic studies—such as chest radiography, computed tomography, electrocardiography, complete blood count, arterial blood gas analysis, pulse oximetry, pulmonary function testing, or echocardiography—supports accurate identification of underlying pathology. Recognition of immediately life-threatening etiologies, including tension pneumothorax, acute airway obstruction, acute myocardial infarction, or massive pulmonary embolism, is essential. Evidence-based interventions targeted to the precipitating disorder, optimization of comorbid conditions, and ongoing reassessment improve clinical outcomes and reduce morbidity. This activity for healthcare professionals is designed to enhance the learner's competence in the evaluation and management of dyspnea by improving diagnostic accuracy, differentiating among cardiac, pulmonary, and nonorganic causes, and applying evidence-based treatment strategies. Learners will strengthen their ability to interpret clinical findings, implement appropriate diagnostic pathways, and coordinate interprofessional care. Participants will also gain a clearer understanding of the prognostic significance of dyspnea across disease states, approaches that support patient-centered management, and communication methods that aid individuals experiencing this clinically significant symptom. Objectives: Determine the etiologic factors contributing to acute and chronic dyspnea to optimize patient care. Apply guideline-directed therapies to manage dyspnea across acute and chronic settings, ensuring appropriate pharmacologic and nonpharmacologic interventions.

This activity for healthcare professionals is designed to enhance the learner's competence in the evaluation and management of dyspnea by improving diagnostic accuracy, differentiating among cardiac, pulmonary, and nonorganic causes, and applying evidence-based treatment strategies. Learners will strengthen their ability to interpret clinical findings, implement appropriate diagnostic pathways, and coordinate interprofessional care. Participants will also gain a clearer understanding of the prognostic significance of dyspnea across disease states, approaches that support patient-centered management, and communication methods that aid individuals experiencing this clinically significant symptom. Objectives: Determine the etiologic factors contributing to acute and chronic dyspnea to optimize patient care. Apply guideline-directed therapies to manage dyspnea across acute and chronic settings, ensuring appropriate pharmacologic and nonpharmacologic interventions. Improve patient understanding of how early recognition of symptoms and compliance with therapy reduce complications. Coordinate ongoing care and follow-up for patients with chronic dyspnea, integrating disease management, patient education, and supportive therapies across care settings. Access free multiple choice questions on this topic.

Dyspnea, commonly described as shortness of breath, is a subjective sensation of uncomfortable or difficult breathing arising from diverse medical, environmental, psychological, and physiological factors. Patients frequently report chest tightness, air hunger, rapid breathing, or a sensation of insufficient air. Dyspnea affects millions worldwide and may serve as the primary manifestation of respiratory, cardiac, neuromuscular, systemic, or psychogenic disorders, or a combination thereof. Psychosocial, cultural, and physiologic factors, including anxiety, depression, hormonal status, obesity, and overall fitness level, influence the perception and severity of dyspnea. Clinically, acute dyspnea develops over hours to days, subacute dyspnea evolves over several days up to 4 weeks, and chronic dyspnea persists for more than 4 weeks.[1][2][3] Effective evaluation requires a systematic approach, beginning with a detailed history and physical examination, supplemented by targeted diagnostics such as chest imaging, electrocardiography (ECG), and limited laboratory testing. Additional assessment may include pulmonary function tests, echocardiography, or advanced imaging guided by clinical suspicion. Management prioritizes identification and treatment of the underlying cause—whether optimizing heart failure therapy, addressing airway obstruction, or providing psychological support—while ensuring symptom relief and patient safety through coordinated, interprofessional care.

Dyspnea, whether acute or chronic, is a symptom of an underlying condition rather than a distinct disease. The etiologies may be broadly classified into 6 primary categories: respiratory, cardiac, neuromuscular, psychogenic, systemic, or multifactorial. Acute dyspnea is most commonly due to either pulmonary or cardiovascular causes. Respiratory causes can be further categorized as diseases of the upper airway, chest wall, diaphragm, or lung parenchyma. Such organization allows clinicians to prioritize potentially life-threatening conditions and streamline evaluation. Upper airway diseases: Laryngeal mass, vocal cord paralysis, inducible laryngeal obstruction, goiter or neck mass compressing the airway Chest wall diseases: Kyphoscoliosis, obesity, ventral hernia, ascites Diaphragmatic disorders: Diaphragmatic paralysis Pulmonary diseases: Asthma, bronchiectasis, bronchiolitis, chronic obstructive pulmonary disease (COPD), interstitial lung disease, pleural effusion, hemothorax, pulmonary hypertension, venous thromboembolism, pulmonary right-to-left shunt, airway occlusion due to a pulmonary mass, bronchospasm, pneumothorax, pneumonia, aspiration, anaphylaxis, bronchitis Cardiovascular causes represent a significant category of dyspnea, as cardiac dysfunction can impair oxygen delivery and hemodynamic stability, often leading to acute or chronic shortness of breath. Prompt recognition of these conditions is critical, as delayed diagnosis or management can result in serious morbidity or mortality. Common cardiovascular etiologies include arrhythmia, cardiomyopathy, cardiac tamponade, congestive heart failure, constrictive pericarditis, coronary artery disease (CAD), deconditioning, intracardiac shunt, restrictive cardiomyopathy, and valvular dysfunction. Other pathologies that can result in breathing difficulty are classified as follows: Neuromuscular diseases: Amyotrophic lateral sclerosis, phrenic nerve dysfunction, glycolytic enzyme dysfunction, mitochondrial diseases, polymyositis or dermatomyositis Toxic, metabolic, or systemic causes: Anemia, carbon monoxide poisoning, metabolic acidosis, renal failure, thyroid disease [4][5][6] Miscellaneous disorders: Anxiety, pregnancy, gastroesophageal reflux disease, trauma

Neuromuscular diseases: Amyotrophic lateral sclerosis, phrenic nerve dysfunction, glycolytic enzyme dysfunction, mitochondrial diseases, polymyositis or dermatomyositis Toxic, metabolic, or systemic causes: Anemia, carbon monoxide poisoning, metabolic acidosis, renal failure, thyroid disease [4][5][6] Miscellaneous disorders: Anxiety, pregnancy, gastroesophageal reflux disease, trauma The diverse causes of dyspnea necessitate a structured approach to diagnosis, with attention to the specific etiology guiding appropriate testing and interventions. Recognition of the underlying mechanism also informs prognosis and ongoing care planning.

Dyspnea is a common reason for emergency department visits, representing roughly 5% of cases each year. The leading causes include lower respiratory tract infection, heart failure, COPD, and asthma, which together account for the majority of presentations. The relative frequency of these conditions varies with patient age and comorbidities.[7] Lower respiratory tract infections, particularly pneumonia, contribute to 20% to 26% of cases, making them the single most common cause in many studies.[8] Heart failure accounts for 15% to 28% of presentations, with the highest rates observed in adults older than 75.[9] COPD exacerbations represent 13% to 18%, typically affecting older adults and individuals with a history of smoking, whereas asthma exacerbations predominate among younger adults and comprise 13% to 15% of visits.[10] Some studies show that COVID-19 has been responsible for up to 17% of dyspnea presentations in recent years. Other, less frequent etiologies include pulmonary embolism, acute coronary syndrome (ACS), anemia, and psychogenic dyspnea, each contributing to fewer than 5% of cases.

Neurophysiological Mechanisms of Dyspnea The severity and presentation of dyspnea can vary independently of measurable physiologic changes, arising from complex interactions among central and peripheral neural pathways. The symptom reflects the integration of afferent signals from chemoreceptors and mechanoreceptors with motor command signals within the central nervous system. Both the automatic (brainstem-mediated) and voluntary (cortical) components of the respiratory motor system contribute to the perception and modulation of breathing effort. Mechanoreceptors in the airways, lungs, and chest wall provide continuous sensory feedback to respiratory centers regarding lung volume and airway status. Three primary types of pulmonary mechanoreceptors are involved: slow-adapting stretch receptors, rapidly adapting or irritant receptors, and juxtacapillary (J) receptors. Slow-adapting stretch receptors convey information about lung inflation, helping to regulate tidal volume and inhibit overexpansion (Hering–Breuer reflex). Rapidly adapting receptors respond to changes in lung volume and to chemical or mechanical irritants, such as inhaled particles or inflammatory mediators. C fibers, originating from J-receptors in the alveolar walls near pulmonary capillaries, are activated by both mechanical and chemical stimuli. These afferents travel via the vagus nerve to the brainstem, influencing respiratory rate, depth, and reflexes such as cough. Peripheral chemoreceptors, located in the carotid bodies at the bifurcation of the common carotid arteries and in the aortic bodies of the aortic arch, primarily monitor arterial oxygen tension. The sensitivity of these receptors increases in hypercapnia and acidosis, augmenting ventilatory drive under hypoxic conditions. Activation triggers afferent impulses via the glossopharyngeal nerve to the nucleus tractus solitarius in the medulla, stimulating excitatory respiratory neurons and increasing ventilation. Carotid bodies contribute approximately 15% of total ventilatory drive under normal conditions and assume a dominant role during hypoxemia.

Peripheral chemoreceptors, located in the carotid bodies at the bifurcation of the common carotid arteries and in the aortic bodies of the aortic arch, primarily monitor arterial oxygen tension. The sensitivity of these receptors increases in hypercapnia and acidosis, augmenting ventilatory drive under hypoxic conditions. Activation triggers afferent impulses via the glossopharyngeal nerve to the nucleus tractus solitarius in the medulla, stimulating excitatory respiratory neurons and increasing ventilation. Carotid bodies contribute approximately 15% of total ventilatory drive under normal conditions and assume a dominant role during hypoxemia. Central chemoreceptors exert primary control over baseline respiratory drive. Located on the ventral surface of the medulla and within the retrotrapezoid nucleus, these receptors respond to changes in cerebrospinal fluid pH, which reflects arterial carbon dioxide (CO2) levels. C02 diffuses freely across the blood-brain barrier, forming carbonic acid and lowering cerebrospinal fluid pH, which stimulates ventilation. Increases in pH, reflecting hypocapnia, suppress ventilation. This tightly regulated feedback system maintains stable arterial CO2 and pH levels during changing metabolic demands. Table 1 summarizes the primary sensory afferent sources involved in respiratory sensation and their clinical relevance. Table Table 1. Sensory Afferent Pathways Involved in the Perception of Dyspnea. Neural Integration and the Perception of Dyspnea Respiratory centers in the medulla oblongata and pons generate the basic rhythm of breathing. Integrated sensory input from peripheral chemoreceptors, which monitor oxygenation, and central chemoreceptors, which detect pH and CO2 levels, continuously modulates this rhythm. Additional modulation occurs via cerebellar and cortical structures that integrate volitional and emotional influences, producing a unified neural signal transmitted to the diaphragm, external intercostals, scalene muscles, and accessory respiratory muscles.[11][12]

Respiratory centers in the medulla oblongata and pons generate the basic rhythm of breathing. Integrated sensory input from peripheral chemoreceptors, which monitor oxygenation, and central chemoreceptors, which detect pH and CO2 levels, continuously modulates this rhythm. Additional modulation occurs via cerebellar and cortical structures that integrate volitional and emotional influences, producing a unified neural signal transmitted to the diaphragm, external intercostals, scalene muscles, and accessory respiratory muscles.[11][12] Dyspnea commonly arises when a mismatch exists between the central respiratory motor command and mechanical or sensory feedback from the lungs, chest wall, or airways. This “afferent–efferent mismatch” occurs when actual mechanical responses, such as airflow obstruction, respiratory muscle weakness, or increased ventilatory demand, fail to meet the perceived need for ventilation. The brain interprets this discrepancy as an uncomfortable awareness of breathing effort, intensifying the sensation of dyspnea. Psychological and emotional factors, including anxiety or heightened awareness of respiration, activate cortical and limbic pathways, further intensifying discomfort and sometimes producing dyspnea disproportionate to physiologic disturbance. These observations highlight the multidimensional nature of dyspnea, integrating sensory, emotional, and cognitive elements.[13] Nonpulmonary Causes of Dyspnea Anemia is a classic nonpulmonary cause of dyspnea. Reduced oxygen-carrying capacity initially triggers increased cardiac output through tachycardia, potentially elevating pulmonary venous pressures and stimulating pulmonary C fibers, contributing to breathlessness. Inadequate oxygen delivery to active skeletal and respiratory muscles can produce local metabolic acidosis, activating muscle metaboreceptors and increasing ventilatory drive. These combined cardiovascular and peripheral mechanisms underlie the sensation of dyspnea in patients with anemia.

Anemia is a classic nonpulmonary cause of dyspnea. Reduced oxygen-carrying capacity initially triggers increased cardiac output through tachycardia, potentially elevating pulmonary venous pressures and stimulating pulmonary C fibers, contributing to breathlessness. Inadequate oxygen delivery to active skeletal and respiratory muscles can produce local metabolic acidosis, activating muscle metaboreceptors and increasing ventilatory drive. These combined cardiovascular and peripheral mechanisms underlie the sensation of dyspnea in patients with anemia. Similarly, patients with chronic lung disease often develop a sedentary lifestyle. Dyspnea in such individuals may result more from deconditioning than from intrinsic lung disease. Deconditioned muscles rely on anaerobic metabolism even during mild activity, producing lactic acid that stimulates ergoreceptors and increases neural output from respiratory centers, accelerating breathing. The precise contribution of local acidosis and ergoreceptor stimulation to dyspnea remains uncertain. Additionally, patients with chronic inactivity may exhibit heightened sensitivity to dyspneic stimuli, perceiving normal exertion as abnormal. Heart failure constitutes a common cardiac cause of dyspnea. Impaired left ventricular function elevates pulmonary venous and capillary pressures, leading to interstitial and alveolar fluid accumulation. Resulting congestion reduces lung compliance, increases the work of breathing, and stimulates J receptors and pulmonary C fibers, which transmit afferent signals via the vagus nerve to the brainstem, producing rapid, shallow breathing and the sensation of air hunger. Reduced cardiac output also limits oxygen delivery to skeletal and respiratory muscles, promoting early anaerobic metabolism, lactic acidosis, and activation of muscle metaboreceptors, further intensifying dyspnea.

Integration of historical context and examination findings helps clinicians determine whether dyspnea arises from respiratory, cardiac, neuromuscular, metabolic, psychogenic, or multifactorial causes, guiding the selection of diagnostic testing and timely intervention. Onset, duration, precipitating factors, and associated symptoms help narrow the underlying etiology. Acute dyspnea suggests conditions such as asthma exacerbation, pneumonia, anaphylaxis, pulmonary embolism, pneumothorax, acute myocardial ischemia, cardiac tamponade, or heart failure. In contrast, chronic or progressive dyspnea is more often due to COPD, interstitial lung disease, amyotrophic lateral sclerosis, or cardiac dysfunction. The quality of dyspnea (eg, “air hunger,” “inability to take a deep breath,” or “chest tightness”) provides additional diagnostic clues. Associated features such as orthopnea, paroxysmal nocturnal dyspnea, wheezing, cough, chest pain, fever, or edema guide differentiation between pulmonary, cardiac, metabolic, or psychogenic causes. Evidence of respiratory distress on physical examination includes tachypnea, use of accessory muscles, nasal flaring, cyanosis, hypoxia, or altered mental status. Inspection, palpation, percussion, and auscultation of the chest may reveal asymmetry, dullness to percussion, wheezes, crackles, or decreased breath sounds, suggesting effusion, consolidation, or obstruction. Findings such as jugular venous distension, displaced apical impulse, murmurs, or gallops indicate a cardiogenic process. Peripheral findings such as clubbing, cyanosis, edema, or muscle wasting may indicate chronic hypoxemia or systemic disease. See Table 2 for a summary of characteristic historical and physical findings associated with major etiologic causes of dyspnea. Table Table 2. Common Causes of Dyspnea and Their Distinguishing Clinical Features. Critical Signs Requiring Immediate Evaluation

Evidence of respiratory distress on physical examination includes tachypnea, use of accessory muscles, nasal flaring, cyanosis, hypoxia, or altered mental status. Inspection, palpation, percussion, and auscultation of the chest may reveal asymmetry, dullness to percussion, wheezes, crackles, or decreased breath sounds, suggesting effusion, consolidation, or obstruction. Findings such as jugular venous distension, displaced apical impulse, murmurs, or gallops indicate a cardiogenic process. Peripheral findings such as clubbing, cyanosis, edema, or muscle wasting may indicate chronic hypoxemia or systemic disease. See Table 2 for a summary of characteristic historical and physical findings associated with major etiologic causes of dyspnea. Table Table 2. Common Causes of Dyspnea and Their Distinguishing Clinical Features. Critical Signs Requiring Immediate Evaluation A heart rate exceeding 120 bpm, respiratory rate above 30/min, pulse oxygen saturation (SpO2) below 90%, use of accessory respiratory muscles, difficulty speaking in full sentences, altered mental status, stridor, asymmetric breath sounds, diffuse crackles, diaphoresis, unstable arrhythmias, and cyanosis are all indicators that urgent evaluation is required. For patients who are unstable at initial presentation, clinicians should perform a rapid assessment and stabilization following the Advanced Trauma Life Support protocol. During the initial rapid assessment, the clinician should inspect the chest for evidence of trauma, such as open wounds, bruising, or asymmetrical chest movement, and examine the neck for tracheal deviation, which may indicate a tension pneumothorax. Lung auscultation evaluates the presence and symmetry of breath sounds, with absent or diminished sounds on one side suggesting pneumothorax or hemothorax. Palpation of the chest wall can detect crepitus from subcutaneous emphysema or flail segments, while percussion identifies hyperresonance indicative of pneumothorax or dullness consistent with hemothorax. Observation of respiratory rate and accessory muscle use provides a measure of dyspnea severity. Assessment of Hemodynamically Stable Patients

During the initial rapid assessment, the clinician should inspect the chest for evidence of trauma, such as open wounds, bruising, or asymmetrical chest movement, and examine the neck for tracheal deviation, which may indicate a tension pneumothorax. Lung auscultation evaluates the presence and symmetry of breath sounds, with absent or diminished sounds on one side suggesting pneumothorax or hemothorax. Palpation of the chest wall can detect crepitus from subcutaneous emphysema or flail segments, while percussion identifies hyperresonance indicative of pneumothorax or dullness consistent with hemothorax. Observation of respiratory rate and accessory muscle use provides a measure of dyspnea severity. Assessment of Hemodynamically Stable Patients For stable patients, a thorough history is essential to guide evaluation and management. Clinicians should obtain a detailed description of events leading to symptom onset, including medication and diet adherence in patients with heart failure, recent allergen exposure or upper respiratory infection in patients with asthma, new food exposures preceding symptoms, vaccination status, and any recent surgery, trauma, or immobilization. Inquiry should also cover exacerbating and relieving factors, as well as changes in symptom severity over time. Past medical history is critical. Clinicians should determine whether the condition is new or recurrent and ask about prior diagnoses such as asthma, CAD, heart failure, deep venous thrombosis, or pulmonary embolism. A history of prior intubation is important, as patients with previous airway interventions may be at increased risk for severe symptoms and require repeat intubation in certain conditions, such as asthma. Associated symptoms, including fever, cough, hemoptysis, chest pain, paroxysmal nocturnal dyspnea, and sputum production, should be documented. Family history of hypercoagulable disorders may increase pulmonary embolism risk. Tobacco, vaping, and recreational drug use should be assessed due to the risk of COPD, malignancy, e-cigarette or vaping product use-associated lung injury (EVALI), pneumonia, empyema, septic emboli, noncardiogenic pulmonary edema, diffuse alveolar damage, hemorrhagic alveolitis, or pneumothorax. While psychiatric history and prior similar episodes may be relevant, clinicians must remember that psychogenic causes of acute dyspnea are diagnoses of exclusion.

Associated symptoms, including fever, cough, hemoptysis, chest pain, paroxysmal nocturnal dyspnea, and sputum production, should be documented. Family history of hypercoagulable disorders may increase pulmonary embolism risk. Tobacco, vaping, and recreational drug use should be assessed due to the risk of COPD, malignancy, e-cigarette or vaping product use-associated lung injury (EVALI), pneumonia, empyema, septic emboli, noncardiogenic pulmonary edema, diffuse alveolar damage, hemorrhagic alveolitis, or pneumothorax. While psychiatric history and prior similar episodes may be relevant, clinicians must remember that psychogenic causes of acute dyspnea are diagnoses of exclusion. Investigation of Potential Causes of Dyspnea A more thorough physical examination is necessary following completion of the initial rapid screen. Clinicians should evaluate multiple systems to identify potential causes of dyspnea. Respiratory assessment begins with the respiratory rate, which may be slow, normal, or rapid in patients with serious underlying illnesses. Pulse oximetry provides a measure of arterial oxygen saturation. However, elevated carboxyhemoglobin, methemoglobin, high glycohemoglobin A1c, or dark skin pigmentation can produce falsely normal or high readings.[14] Conversely, severe anemia, ambient light, nail polish, hemoglobin S, and inherited abnormal hemoglobins may yield falsely low SpO2 values. Breath sounds offer additional diagnostic insight. Inspiratory stridor typically indicates upper airway obstruction above the vocal cords, whereas expiratory or mixed stridor generally indicates obstruction below the vocal cords. Wheezing from bronchoconstriction may occur in asthma, acute decompensated heart failure, anaphylaxis, foreign body aspiration, or tumors. Interalveolar fluid produces crackles, most commonly in pneumonia or acute decompensated heart failure. Conditions that limit airflow, such as severe asthma, COPD, pneumothorax, pleural effusion, or hemothorax, result in decreased breath sounds.

Breath sounds offer additional diagnostic insight. Inspiratory stridor typically indicates upper airway obstruction above the vocal cords, whereas expiratory or mixed stridor generally indicates obstruction below the vocal cords. Wheezing from bronchoconstriction may occur in asthma, acute decompensated heart failure, anaphylaxis, foreign body aspiration, or tumors. Interalveolar fluid produces crackles, most commonly in pneumonia or acute decompensated heart failure. Conditions that limit airflow, such as severe asthma, COPD, pneumothorax, pleural effusion, or hemothorax, result in decreased breath sounds. Cardiovascular examination provides critical clues. Clinicians should evaluate for dysrhythmia, murmurs, 3rd- and 4th-heart sounds, muffled heart sounds, jugular venous distension, and pulsus paradoxus. An S3 gallop indicates increased left ventricular filling pressures, as seen in systolic dysfunction or congestive heart failure, whereas an S4 gallop reflects decreased left ventricular compliance, associated with left ventricular hypertrophy, ischemic heart disease, or diastolic dysfunction. A loud P2 component of the 2nd heart sound suggests pulmonary hypertension. Murmurs may indicate valvular stenosis or regurgitation. Diminished heart sounds can suggest pericardial effusion or tamponade, and a pericardial friction rub is characteristic of pericarditis, best heard along the left sternal border with the patient leaning forward. Abdominal examination may reveal distension due to a perforated viscus, ascites from liver disease or malignancy, or obesity, all of which can contribute to dyspnea. Skin inspection should note cyanosis or pallor, which provides additional diagnostic clues.[15][16][17]

The evaluation of dyspnea requires a structured, stepwise approach that integrates patient history, focused physical examination, and selective diagnostic testing. Dyspnea may arise from pulmonary, cardiac, hematologic, neuromuscular, or psychogenic causes. Clinicians must synthesize multiple data points to determine the underlying etiology and guide timely management. History and physical examination findings inform the selection of diagnostic tests. Most patients with acute dyspnea undergo a chest radiograph, ECG, complete blood count with differential, and serum electrolytes, including bicarbonate. These investigations assist in diagnosing conditions such as heart failure, pneumonia, cardiac ischemia, pneumothorax, cardiomyopathy, high-altitude pulmonary edema, pleural effusion, hemothorax, malignancy, EVALI, acute chest syndrome, infection, anemia, diabetic ketoacidosis, and airway foreign bodies. Initial Diagnostic Evaluation Bedside ultrasound in patients with acute dyspnea assists in evaluating left ventricular function, pericardial effusion, tension pneumothorax, pleural effusion, cardiac wall motion abnormalities, right heart strain in pulmonary embolism, and proximal deep vein thrombosis (DVT).[18] The BLUE (Bedside Lung Ultrasound in Emergency) protocol, developed by Lichtenstein et al, provides a standardized point-of-care approach to assess patients with acute dyspnea rapidly. The protocol examines 3 specific thoracic zones on each side: the upper BLUE point, the lower BLUE point, and the posterolateral alveolar and pleural syndrome (PLAPS) point. Characteristic ultrasound patterns, or “profiles,” correspond to distinct causes of respiratory distress. For example, A-lines with normal lung sliding (A-profile) suggest COPD or asthma. Bilateral B-lines (B-profile) indicate pulmonary edema. Absent lung sliding with A-lines (A′-profile) suggests pneumothorax. The BLUE protocol enables rapid, bedside differentiation of common causes of respiratory failure.[19] Further Diagnostic Assessment Computed tomography (CT) of the chest is not routinely indicated for all patients presenting with dyspnea. CT is most valuable in patients with trauma-related dyspnea or inconclusive chest radiography results. Potential risks of CT include contrast-induced nephropathy, allergic reactions to contrast, and radiation-related malignancy.

Computed tomography (CT) of the chest is not routinely indicated for all patients presenting with dyspnea. CT is most valuable in patients with trauma-related dyspnea or inconclusive chest radiography results. Potential risks of CT include contrast-induced nephropathy, allergic reactions to contrast, and radiation-related malignancy. Plain radiography of the neck may detect findings associated with retropharyngeal abscess, epiglottitis, or a radiopaque foreign body. If a deep neck space infection or radiopaque foreign body is suspected, CT of the neck is warranted. When CT is negative but suspicion remains, flexible laryngoscopy can identify foreign bodies in the upper airway (above the vocal cords), while flexible or rigid bronchoscopy is used to detect foreign bodies in the lower airway. Arterial blood gas analysis is not routinely required unless the accuracy of pulse oximetry is uncertain. Venous blood gas measurement, combined with serum bicarbonate levels, may be used to evaluate the patient’s acid-base status. Cardiac biomarkers, such as troponin I, are used to evaluate myocardial ischemia in conjunction with the ECG. Initial values may be normal, and serial measurements are often required. Brain natriuretic peptide assists in establishing the diagnosis of acute heart failure. Testing for respiratory viruses, such as COVID-19, should be performed as clinically indicated. Assessment for influenza is particularly important during the respiratory virus season. Pulmonary embolism evaluation combines D-dimer testing with CT pulmonary angiography (CTPA). Patients are first stratified according to the Wells criteria for probability of DVT. Individuals with low probability who meet all 8 Pulmonary Embolism Rule-Out Criteria (PERC) require no further testing. Patients who do not meet these criteria or have intermediate probability undergo D-dimer testing. A D-dimer level below 500 ng/mL indicates a low likelihood of DVT or pulmonary embolism and typically requires no additional evaluation. Levels of 500 ng/mL or higher warrant further imaging, preferably CTPA. Ventilation-perfusion (V/Q) scanning is utilized when CTPA is unavailable or inconclusive. Echocardiography aids in assessing papillary muscle or interventricular septal rupture. A peak flow meter helps differentiate pulmonary from cardiac causes of dyspnea and evaluates the severity of bronchoconstriction in severe asthma.

Pulmonary embolism evaluation combines D-dimer testing with CT pulmonary angiography (CTPA). Patients are first stratified according to the Wells criteria for probability of DVT. Individuals with low probability who meet all 8 Pulmonary Embolism Rule-Out Criteria (PERC) require no further testing. Patients who do not meet these criteria or have intermediate probability undergo D-dimer testing. A D-dimer level below 500 ng/mL indicates a low likelihood of DVT or pulmonary embolism and typically requires no additional evaluation. Levels of 500 ng/mL or higher warrant further imaging, preferably CTPA. Ventilation-perfusion (V/Q) scanning is utilized when CTPA is unavailable or inconclusive. Echocardiography aids in assessing papillary muscle or interventricular septal rupture. A peak flow meter helps differentiate pulmonary from cardiac causes of dyspnea and evaluates the severity of bronchoconstriction in severe asthma. Additional testing may include measurement of negative inspiratory force to assess patients with suspected neuromuscular disease, such as myasthenia gravis or Guillain-Barré syndrome. Blood and sputum cultures are indicated when infection is presumed to cause dyspnea, for example, in pneumonia or sepsis. Sputum cultures identify the specific pathogen responsible for lower respiratory tract infection, allowing targeted antibiotic therapy. Blood cultures determine whether the infection has entered the bloodstream, which influences disease severity and guides treatment intensity. These tests are particularly valuable when dyspnea is accompanied by fever, productive cough, leukocytosis, or other signs of systemic illness.[20][21][22][23] Evaluation for anemia typically includes a complete blood count, iron studies, vitamin B12 and folate levels, and markers of hemolysis, with bone marrow examination reserved for unexplained cytopenias. Patients may also require an endoscopy to evaluate for an underlying malignancy.

Dyspnea is a symptom rather than a distinct disease. Therefore, management should target the underlying etiology. The following section provides a concise overview of treatment approaches for common causes of dyspnea. Management of Acute Dyspnea Management of acute dyspnea begins with rapid stabilization of the airway, breathing, and circulation before pursuing diagnosis.[24][25][26] All patients should undergo pulse oximetry and cardiac monitoring, receive supplemental oxygen as indicated (target SpO2 of 94% for most patients and 88%–92% for patients with COPD), and have intravenous access established. If respiratory failure is imminent, clinicians should maintain a low threshold for endotracheal intubation. When appropriate, high-flow nasal cannula or noninvasive ventilation, such as continuous positive airway pressure (CPAP) or bilevel positive airway pressure (BiPAP), may be employed. Contraindications to noninvasive ventilation include coma, cardiac arrest, respiratory arrest, gastrointestinal bleeding, cardiac instability, status epilepticus, potential upper airway obstruction, and inability to protect the airway. Bedside assessments and point-of-care ultrasound facilitate rapid identification of life-threatening conditions. Tension pneumothorax requires immediate needle decompression followed by tube thoracostomy. Hemothorax or large pleural effusions are managed with therapeutic thoracentesis or chest tube placement. Cardiac tamponade necessitates urgent pericardiocentesis. Asthma and COPD exacerbations are treated with inhaled bronchodilators and systemic corticosteroids. Noninvasive ventilation is used when appropriate, with endotracheal intubation if ventilation continues to worsen. Pulmonary edema from heart failure improves with noninvasive ventilation, diuretics, and afterload reduction. Pulmonary embolism requires prompt anticoagulation, while hemodynamically unstable patients may require thrombolysis or embolectomy. ACS necessitates antiplatelet therapy, anticoagulation, and a reperfusion strategy such as percutaneous coronary intervention or thrombolysis. Anaphylaxis or upper-airway edema requires immediate intramuscular epinephrine and preparation for definitive airway control.

Pulmonary edema from heart failure improves with noninvasive ventilation, diuretics, and afterload reduction. Pulmonary embolism requires prompt anticoagulation, while hemodynamically unstable patients may require thrombolysis or embolectomy. ACS necessitates antiplatelet therapy, anticoagulation, and a reperfusion strategy such as percutaneous coronary intervention or thrombolysis. Anaphylaxis or upper-airway edema requires immediate intramuscular epinephrine and preparation for definitive airway control. Pneumonia is a frequent cause of dyspnea requiring hospitalization. Tools such as the CURB-65 (confusion, urea >7 mmol/L, respiratory rate ≥30/min, blood pressure with systolic blood pressure <90 mm Hg or diastolic blood pressure ≤60 mm Hg, and age ≥65) score help determine severity and the need for intensive monitoring. Management includes supplemental oxygen and empiric antibiotics, with blood and sputum cultures—and viral testing when indicated—to guide targeted therapy, especially during outbreaks of pathogens such as influenza, SARS-CoV-2, or MERS-CoV. Management of Chronic Dyspnea For patients with COPD, management follows the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines. Pulmonary rehabilitation benefits patients with persistent symptoms despite optimal therapy.[27] Individuals with chronic hypoxemia, characterized by a maximum resting arterial oxygen tension of 55 mm Hg or a maximum SpO2 of 88%, should receive long-term home oxygen therapy. The Global Initiative for Asthma (GINA) guidelines direct asthma treatment and emphasize inhaled bronchodilators, inhaled corticosteroids, leukotriene receptor antagonists, and avoidance of known triggers.[28] Psychogenic dyspnea, such as that associated with anxiety or panic attacks, requires management only after serious cardiopulmonary causes have been excluded. Treatment may include selective serotonin reuptake inhibitors, selective serotonin and norepinephrine reuptake inhibitors, and referral for cognitive behavioral therapy. Neuromuscular etiologies of dyspnea are treated with disease-specific therapies that address the underlying pathophysiology.

Psychogenic dyspnea, such as that associated with anxiety or panic attacks, requires management only after serious cardiopulmonary causes have been excluded. Treatment may include selective serotonin reuptake inhibitors, selective serotonin and norepinephrine reuptake inhibitors, and referral for cognitive behavioral therapy. Neuromuscular etiologies of dyspnea are treated with disease-specific therapies that address the underlying pathophysiology. In CAD, management includes antiplatelet and anticoagulant therapy, coronary angiography, and revascularization when indicated. Patients with congestive heart failure should receive guideline-directed medical therapy, including diuretics, an angiotensin receptor blocker–neprilysin inhibitor, a mineralocorticoid receptor antagonist, a β-blocker, and a sodium-glucose cotransporter 2 (SGLT2) inhibitor, to reduce symptoms and prevent adverse cardiac remodeling. When dyspnea is secondary to anemia, treatment focuses on identifying and correcting the underlying cause. Iron supplementation is used for iron deficiency, and vitamin B12 or folate replacement is indicated in megaloblastic anemia. The 6-minute walk test provides a practical assessment of functional capacity and treatment response in patients with pulmonary or cardiac disease. The patient walks at a self-selected pace for 6 minutes, and breathlessness is rated before and after using the modified Borg scale (0–10).[29] Since dyspnea is a subjective experience, patient-reported outcome measures, such as the Numeric Rating Scale (NRS), Visual Analog Scale (VAS), modified Borg Scale, and the modified Medical Research Council (mMRC) scale, are essential for clinical assessment. These tools are quick to administer, easy to interpret, and valid across diverse conditions, including COPD, interstitial lung disease, heart failure, and advanced cancer. These assessments enable clinicians to quantify dyspnea severity and distress and to monitor response to therapy over time. Multidimensional instruments such as the Dyspnea-12 and the Multidimensional Dyspnea Profile further evaluate the sensory qualities, emotional burden, and functional impact of breathlessness, supporting more individualized care planning. The mMRC scale is particularly common in routine practice, as it grades activity limitation and helps predict outcomes such as mortality in COPD.[30]

The following list provides some of the most common differential diagnoses of dyspnea: Amyotrophic lateral sclerosis Anaphylaxis Anemia Anxiety Arrhythmia Ascites Aspiration Asthma Bronchiectasis Bronchiolitis Cardiac tamponade Chest or abdominal wall restriction, such as kyphoscoliosis, massive obesity, late pregnancy, or ventral hernia Constrictive pericarditis or pericardial effusion COPD or emphysema Coronary heart disease Deconditioning Diaphragmatic paralysis Early pregnancy (progesterone effect) Foreign body Glycolytic enzyme defects (eg, McArdle disease) Goiter Heart failure (systolic or diastolic) Hemothorax Inducible laryngeal obstruction (paradoxical vocal fold motion) Intra-abdominal processes such as ascites Interstitial lung disease Intracardiac shunt Kyphoscoliosis (included above in chest/abdominal restriction) Laryngeal mass Malignancy Metabolic acidosis Mitochondrial diseases Neck mass Neuromuscular disease Phrenic nerve dysfunction Pleural effusion Pneumonia Pneumothorax Polymyositis/dermatomyositis Previous major lung resection Pulmonary hypertension Pulmonary right-to-left shunt Renal failure Restrictive cardiomyopathy Thyroid disease Venous thromboembolism Vocal fold paralysis A careful history, focused physical examination, and targeted testing are essential to isolate the true cause of dyspnea. Early recognition and management of the underlying condition help prevent deterioration and improve outcomes.

Dyspnea is a symptom rather than a disease, and its prognosis depends entirely on the underlying etiology. Across both emergency and outpatient settings, dyspnea consistently portends increased short- and long-term mortality. Patients presenting with dyspnea to the emergency department have markedly higher admission rates and up to a 5-fold increase in mortality when compared with those presenting with chest pain. Dyspnea independently predicts 1-year mortality in ACS and is associated with a higher risk of atrial fibrillation and myocardial infarction, even in individuals without known cardiopulmonary disease. Patients with dyspnea but no CAD have a 4-fold increased risk of sudden cardiac death compared with asymptomatic individuals and more than twice the risk compared with those who have angina. Dyspnea is an independent predictor of adverse outcomes among patients with conditions such as acute myocardial infarction or COPD. The degree of breathlessness during daily activities—quantified using validated scales such as the Medical Research Council or modified mMRC dyspnea scale, often supplemented by the 6-minute walk test—correlates strongly with mortality in COPD, interstitial lung disease, pulmonary hypertension, heart failure, and even in the general population without diagnosed cardiopulmonary disease.

Complications associated with dyspnea depend on the underlying cause, severity, and duration of illness. Both physiologic and psychosocial sequelae are common. Potential complications include the following: Respiratory failure Atelectasis and pneumonia Acid-base disturbances Structural lung injury Pulmonary hypertension Heart failure Arrhythmias Pulmonary edema Increased risk of stroke and myocardial infarction Sudden cardiac death Deconditioning and exercise intolerance Respiratory muscle fatigue Cachexia Osteoporosis (particularly in patients on long-term corticosteroids) Anxiety and panic symptoms related to breathlessness Depression and overall reduction in quality of life Close clinical monitoring and proactive management of underlying disease reduce the likelihood of serious complications related to dyspnea. Educating patients to recognize warning signs helps ensure prompt care and improves long-term health.

Dyspnea, or shortness of breath, is the subjective sensation of breathing discomfort. This disease manifestation may present acutely or chronically and can result from a wide range of underlying conditions affecting the lungs, heart, blood, or neuromuscular system. Healthcare professionals should emphasize to patients that dyspnea is a symptom, not a diagnosis, and warrants thorough assessment to determine its etiology. Patient education should prioritize recognition of red flag symptoms, including rapidly worsening dyspnea, chest pain, syncope, hemoptysis, or peripheral edema. Patients must be instructed to seek immediate medical care if these features occur, as they may indicate life-threatening conditions such as acute heart failure, pulmonary embolism, or myocardial infarction. For patients with chronic respiratory or cardiac conditions such as asthma, COPD, or heart failure, clinicians must provide education on proper inhaler or medication technique, self-monitoring for signs of exacerbation, and clear criteria for when to contact a healthcare provider. Additionally, clinicians should stress the importance of lifestyle modifications, including smoking cessation, weight management, graded exercise, and adherence to vaccinations (influenza, pneumococcal, and COVID-19), to reduce symptom recurrence and improve prognosis. Additional strategies should prioritize reducing the risk of cardiopulmonary disease by promoting smoking cessation, minimizing environmental exposures such as secondhand smoke and occupational irritants, and ensuring strict adherence to prescribed therapy. Routine follow-up visits, early intervention for infections, and prompt management of symptom exacerbations can decrease acute care utilization and prevent complications. Healthcare professionals should also support public health efforts by emphasizing that new or worsening dyspnea, particularly when accompanied by chest pain, presyncope, or cyanosis, requires urgent evaluation. Early identification and treatment of underlying etiologies are essential to reducing morbidity and mortality associated with dyspnea.

Dyspnea, commonly described as shortness of breath or difficulty breathing, is a subjective experience of breathing discomfort that varies in intensity and quality. The symptom arises from complex interactions among physiologic, psychological, social, and environmental factors and involves multiple pathways affecting the respiratory, cardiovascular, neuromuscular, and hematologic systems. Healthcare professionals must recognize dyspnea as a symptom rather than a diagnosis, reflecting a wide variety of underlying conditions. The perception of dyspnea results from an imbalance between ventilatory demand and the respiratory system’s capacity to meet that demand. Assessment requires a detailed history and physical examination, supplemented by targeted diagnostic testing to identify the etiology and guide management. Understanding the pathophysiology and multidimensional nature of dyspnea enables clinicians to deliver timely, patient-centered care. Effective management of dyspnea requires a coordinated, interprofessional approach involving physicians, advanced practitioners, nurses, pharmacists, respiratory therapists, and other allied healthcare professionals. Clear communication, shared decision-making, and seamless transitions of care across settings optimize patient outcomes. Physicians and advanced practitioners apply clinical knowledge and proficiency in interpreting diagnostic data, such as arterial blood gases, D-dimer, chest imaging, and brain natriuretic peptide levels, to promptly recognize life-threatening conditions and guide management. Nurses are often the first to detect changes in respiratory status, initiate oxygen therapy, and escalate care when deterioration occurs. Through ongoing patient education, nurses reinforce medication adherence, inhaler technique, and breathing exercises to help patients manage symptoms effectively.

Physicians and advanced practitioners apply clinical knowledge and proficiency in interpreting diagnostic data, such as arterial blood gases, D-dimer, chest imaging, and brain natriuretic peptide levels, to promptly recognize life-threatening conditions and guide management. Nurses are often the first to detect changes in respiratory status, initiate oxygen therapy, and escalate care when deterioration occurs. Through ongoing patient education, nurses reinforce medication adherence, inhaler technique, and breathing exercises to help patients manage symptoms effectively. Nurses collaborate closely with physicians, advanced practitioners, respiratory therapists, and pharmacists to coordinate care, implement treatment plans, and ensure clear communication across all stages of care. Pharmacists assist with medication reconciliation, optimize inhaler or diuretic regimens, and educate patients on correct use and potential side effects. Respiratory therapists adjust oxygen delivery and monitor ventilatory support. Case managers and social workers facilitate continuity of care after discharge, ensuring access to medications, rehabilitation programs, and home oxygen therapy when indicated. Effective communication among team members promotes timely intervention and reduces duplication or medical errors. Regular interprofessional case reviews and standardized handoff protocols ensure that physicians, nurses, pharmacists, respiratory therapists, and social workers share consistent information regarding diagnoses, treatments, and patient responses. Clear communication with patients and families builds trust and enhances adherence to management plans, particularly for chronic conditions such as COPD, asthma, and heart failure. A collaborative approach that emphasizes patient-centered care and addresses both the physical and emotional aspects of breathlessness improves satisfaction, safety, and clinical outcomes.